Clinical trial
Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia
NCT02994446 is registered in ClinicalTrials.gov with Thermedical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia
- Lead sponsor
- Thermedical, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- October 4, 2021
- Enrollment
- 25 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.